We are an integrated psychedelic drug discovery company
Our scientific team is led by world-class experts in neurodegenerative diseases, pharmacology and chemistry.
We are specialized in developing novel proprietary psychedelic molecules resulting in more controlled and safer experiences, and no hallucinogenic effects. Our intellectual property is secured.
Through our exclusive partnership with the University of Messina we discover, synthesize and trial novel psychedelics molecules in one place.
We have full expertise in drug and clinical development, regulatory affairs and psychedelic-specific manufacturing.
Driven to help patients suffering from neuroinflammation
We focus on prevalent neuroinflammatory disorders where traditional treatments have fallen short.
Scientific studies show that certain psychedelic molecules have powerful anti-inflammatory properties. Our proprietary molecules can help control peripheral and central neuroinflammation without hallucinogenic effects.
Specialized in proprietary psychedelic molecules
Targeted formulations with improved safety profiles
With our partner, we synthesize new molecules in-house.
Our formulations have improved safety profiles and unique features.